BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21392208)

  • 1. Comparison of the new American Joint Committee on Cancer substratification in node-negative pT2 urothelial carcinoma of the bladder: analysis of patient outcomes in a contemporary series.
    Gakis G; Schilling D; Renninger M; Seibold J; Sievert KD; Stenzl A
    BJU Int; 2011 Mar; 107(6):919-23. PubMed ID: 21392208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
    Bolenz C; Herrmann E; Bastian PJ; Michel MS; Wülfing C; Tiemann A; Buchner A; Stief CG; Fritsche HM; Burger M; Wieland WF; Höfner T; Haferkamp A; Hohenfellner M; Müller SC; Ströbel P; Trojan L
    BJU Int; 2010 Aug; 106(4):493-9. PubMed ID: 20067452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of radical cystectomy.
    Thalmann GN; Stein JP
    BJU Int; 2008 Nov; 102(9 Pt B):1279-88. PubMed ID: 19035893
    [No Abstract]   [Full Text] [Related]  

  • 12. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome.
    Tilki D; Reich O; Karakiewicz PI; Novara G; Kassouf W; Ergün S; Fradet Y; Ficarra V; Sonpavde G; Stief CG; Skinner E; Svatek RS; Lotan Y; Sagalowsky AI; Shariat SF
    Eur Urol; 2010 Jul; 58(1):112-7. PubMed ID: 20097469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K
    Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal extension in node-positive bladder cancer: the continuing controversy.
    Jeong IG; Ro JY; Kim SC; You D; Song C; Hong JH; Ahn H; Kim CS
    BJU Int; 2011 Jul; 108(1):38-43. PubMed ID: 21070576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens.
    Resnick MJ; Bergey M; Magerfleisch L; Tomaszewski JE; Malkowicz SB; Guzzo TJ
    BJU Int; 2011 Jan; 107(1):46-52. PubMed ID: 20880163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphadenectomy for bladder cancer: indications and controversies.
    Burkhard FC; Roth B; Zehnder P; Studer UE
    Urol Clin North Am; 2011 Nov; 38(4):397-405, v. PubMed ID: 22045171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy].
    Leissner J; Allhoff EP; Hohenfellner R; Wolf HK
    Zentralbl Chir; 2002 Apr; 127(4):315-21. PubMed ID: 12085284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.